QUOTE AND NEWS
Globe Newswire  Jul 19  Comment 
TIRAT CARMEL, Israel, July 19, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or the "Company"), announced today that on July 17, 2012, the Company received a delisting notice from the staff of The NASDAQ
Benzinga  Jul 3  Comment 
Clear Channel Outdoor Holdings (NYSE: CCO) shares lost 4.96% to create a new 52-week low of $5.75. Clear Channel Outdoor's PEG ratio is -4.14. D. Medical Industries Ltd (NASDAQ: DMED) shares fell 15.97% to touch a new 52-week low of $0.21. D....
StreetInsider.com  Jun 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/D.+Medical+%28DMED%29+in+Talks+for+Possible+Diabetes+Medical+Devices+Acquisition/7526026.html for the full story.
Globe Newswire  Jun 19  Comment 
TIRAT CARMEL, Israel, June 19, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or the "Company"), announced today that it is negotiating a potential acquisition transaction with an unaffiliated third party
Globe Newswire  Jun 11  Comment 
TIRAT CARMEL, Israel, June 11, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or the "Company") announced today that it has retained Chicago-based Healthios Capital Markets, LLC, a leading advisory firm
Globe Newswire  Jun 7  Comment 
TIRAT CARMEL, Israel, June 7, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or the "Company"), announced today that its indirect subsidiary, Spring Health Solutions Inc. ("Spring Health"), has signed a
Globe Newswire  Jun 4  Comment 
TIRAT CARMEL, Israel, June 4, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or the "Company"), announced today that its subsidiaries, Spring Health Solutions Ltd. and Spring Set Health Solutions Ltd.
Benzinga  May 15  Comment 
Below are highlights from Benzinga's daily coverage of microcap securities making big moves: Morris Business Development Company Shares of Morris Business Development Company (MBDE), the Redondo Beach, CA service provider for public and...
Globe Newswire  May 14  Comment 
TIRAT CARMEL, Israel, May 14, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or the "Company"), announced today that its subsidiaries, Spring Health Solutions Ltd. and Spring Set Health Solutions Ltd.
Globe Newswire  May 10  Comment 
TIRAT CARMEL, Israel, May 10, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or the "Company") announced today that it received a letter from The NASDAQ Stock Market LLC ("NASDAQ") on May 7, 2012,




 
TOP CONTRIBUTORS

D. Medical (NASDAQ:DMED): is an Israeli based biotechnology company which researches, develops, makes and sells devices to help the treatment and delivery of drugs for diabetes. The company focuses on insulin pumps, which deliver consistent dosages of insulin into a patients bloodstream overtime. While insulin pumps are currently available for sale, D. Medical's pumps rely on springs which are far cheaper than the standard motor driven pump. The company has developed both durable and nondurable pumps.[1]

While D. Medical is focused mostly in Europe, it also plans to focus on expanding into Mexico and the emerging markets, "BRIC" countries (Brazil, Russia, India, and China). They have already reached distribution agreements in Mexico and in China.[2] DMED plans to focus on these developing regions, such as the Western Pacific (which includes China), which has 4.8 times the number of diabetics than North America, but spends only 18% of what North Americans spend on healthcare. The company expects to take advantage of the rising income and awareness in these regions to sell their cheaper insulin pumps.[3]

The company's initial public offering of stock is filed on the NASDAQ and occurred on August 4th, 2010. Its initial price range is $10-$12, but the company priced far below the range at $7. The company planed to offer 1.88M, but also cut the offer size down to 1.5M. While the deal was originally supposed to be worth approximately $21M, it ended up being $10.5M. The lead underwriters of the deal are Rodman & Renshaw Capital (RODM) and ThinkEquity.[4]

D. Medical has began generating revenue in 2009 as its first pump entered the market. However, the company only has generated $99K in 2009 in revenue due to its recent launch. The company's expenses also fell slightly causing net income to rise from -21M NIS (Israeli New Shekel) down to -19M NIS. This slightly drop in expenses is due to a decrease in research and development costs.[5]

References

  1. DMED F-1/A 2010 "Prospectus Summary" pg 1
  2. DMED F-1/A 2010 "Business Overview" pg 82
  3. DMED F-1/A 2010 "Worldwide Prevalence of Diabetes" pg 76
  4. Renaissance IPO - D. Medical (DMED)
  5. TSRX S-1A 2010 "Consolidated Statements of Comprehensive Loss Data" pg 64
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki